The Patent Finder

Medrx Co., Ltd.

Also on record
Records under this name other than the patents Medrx Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 25 patents it holds.

Back to Medrx Co., Ltd.

PatentTitleStatus Expires Confidence
US 11,267,023Hearing device restoration device, system, and methods therefor
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,016,502Patch Preparation Containing an Acid Scavenger
Lapsed on the fee record
Ended Jul 10, 2026 · High confidence
Lapsed on the fee recordEnded Jul 10, 2026High confidence
US 8,623,387External preparation composition comprising fatty acid-based ionic liquid as active ingredient
Lapsed on the fee record
Ended Jan 7, 2026 · From the USPTO record
Lapsed on the fee recordEnded Jan 7, 2026From the USPTO record
US 11,167,119Microneedle patch applicator and housing for same
Lapsed on the fee record
Ended Nov 9, 2025 · From the USPTO record
Lapsed on the fee recordEnded Nov 9, 2025From the USPTO record
US 11,141,387Memantine-containing transdermally absorbable liquid
Lapsed on the fee record
Ended Oct 12, 2025 · From the USPTO record
Lapsed on the fee recordEnded Oct 12, 2025From the USPTO record
US 11,116,953Microneedle applicator and microneedle patch application device
Lapsed on the fee record
Ended Sep 14, 2025 · From the USPTO record
Lapsed on the fee recordEnded Sep 14, 2025From the USPTO record
US 9,750,924Adhesive patching aid for microneedle adhesive skin patch
Lapsed on the fee record
Ended Sep 5, 2025 · From the USPTO record
Lapsed on the fee recordEnded Sep 5, 2025From the USPTO record
US 8,697,096Tape preparation comprising etodolac in ionic liquid form
Lapsed on the fee record
Ended Apr 15, 2022 · From the USPTO record
Lapsed on the fee recordEnded Apr 15, 2022From the USPTO record
US 7,655,687Anti-inflammatory analgesic for external use
Lapsed on the fee record
Ended Feb 2, 2022 · From the USPTO record
Lapsed on the fee recordEnded Feb 2, 2022From the USPTO record
US 8,815,261Composition for external application comprising aripiprazole and organic acid as active ingredients
Lapsed on the fee record
Ended Aug 26, 2018 · From the USPTO record
Lapsed on the fee recordEnded Aug 26, 2018From the USPTO record
10 of 18 patents shown.
Pro members see all 18.
Pro members: see all 18 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited